SAFECHAIN™ | Infected Blood Inquiry

SAFECHAIN™ EVIDENCE REPOSITORY™

PUBLIC INQUIRIES | Evidence Repository Hub 5: Public Inquiries

safe-chain.org | samantha@safe-chain.org

INFECTED BLOOD INQUIRY

Category: Statutory Public Inquiry

Jurisdiction: United Kingdom

Chair: Sir Brian Langstaff

Established: July 2018

Final Report: May 2024

Repository Reference: EVIDENCE-REPOSITORY-INQ-003

INTRODUCTION

The Infected Blood Inquiry examined the contaminated blood scandal — the worst treatment disaster in NHS history — in which approximately 3,000 people died and tens of thousands were infected with HIV and hepatitis C through contaminated blood and blood products given to them as NHS patients. People with haemophilia were given clotting factor concentrates made from pooled blood donations, including donations from high-risk populations, and many received blood transfusions contaminated with HIV and hepatitis C. The scandal spanned the 1970s, 1980s, and 1990s, and its cover-up extended for decades beyond.

The Inquiry's Final Report, published in May 2024, is the most comprehensive documented examination of sustained institutional cover-up, accountability suppression, and governance culture failure in NHS history. It is of direct relevance to the SAFECHAIN™ programme because it provides the definitive evidence base for understanding how governance cultures that prioritise institutional reputation over individual harm can suppress intelligence, suppress accountability, and cause harm at

PURPOSE

The Inquiry examined how patients came to be given infected blood and blood products; what was known by government, NHS bodies, and others about the risks; what was done to establish the extent of the problem; how patients were treated — both medically and by the system; and what steps were taken to support those who were harmed and their families.

WHAT IS IT?

The Infected Blood Inquiry Final Report runs to over 2,500 pages across seven volumes. Its findings represent the most detailed independent examination of NHS governance failure, medical ethics violation, and institutional cover-up ever conducted in the United Kingdom.

THE SCALE OF HARM

Approximately 1,250 people with haemophilia and others received blood products contaminated with HIV. Around 5,000 people with haemophilia were infected with hepatitis C. Approximately 26,800 others received hepatitis C-contaminated blood transfusions. An estimated 3,000 people died as a result of their infections, with ongoing mortality continuing among those still living with the consequences.

WHAT WAS KNOWN AND WHEN

The Inquiry found that the risks of using pooled clotting factor concentrates — including concentrates sourced from paid donors in the United States, including prisoners and others from high-risk populations — were known or should have been known to clinicians, government officials, and NHS bodies. Decisions were taken to continue using these products despite available evidence of the associated risks. Warnings from clinicians and researchers were not acted on. When HIV emerged in the early 1980s, the response was inadequate and delayed.

THE COVER-UP

The Inquiry found that there was a cover-up — that documents were destroyed, that the scale of infections was not disclosed to patients, that patients were not told what they had been given or that they had been infected, and that the NHS and government response was designed to manage legal liability rather than to acknowledge harm, support patients, and prevent further infections. Patients who sought information were misled. The Macfarlane Trust — the compensation body established for those infected with HIV — was deliberately underfunded. And successive governments failed to conduct or commission an adequate inquiry despite the scale of the known harm.

WHY DOES IT MATTER?

The Infected Blood Inquiry matters for governance because it documents the full lifecycle of institutional failure and cover-up — from the initial governance decisions that allowed harm to occur, through the governance failure to disclose and investigate when harm became apparent, to the decades-long governance culture of suppression that prevented accountability until the Inquiry forced it. It demonstrates that the governance failures that produce preventable harm are not limited to operational decisions made under time pressure: they include the subsequent governance decisions to suppress intelligence, resist accountability, and protect institutional reputation at the cost of the individuals harmed.

For the SAFECHAIN™ programme, the Infected Blood case provides the most severe evidential test of the programme's governance principles. The SAFECHAIN™ accountability architecture — specifically the requirement that significant governance decisions are recorded, attributed, and auditable from the moment they occur — is designed precisely to prevent the kind of retrospective suppression that the Infected Blood case documents. An IAR™ record that exists from the moment of a governance decision cannot be destroyed decades later to avoid accountability for that decision.

KEY FINDINGS (FINAL REPORT, MAY 2024)

The contaminated blood scandal was not an accident or an unfortunate consequence of medical uncertainty: decisions were taken that put patients at risk, and those decisions were taken despite available evidence of the risks.

There was a cover-up: this was not the behaviour of a few rogue individuals but a systemic response involving the NHS, government, and others that caused additional harm beyond the initial infections.

Patients were not told the truth about what they had been given, what the risks were, or that they had been infected.

Documents were deliberately destroyed to prevent accountability.

Successive governments and NHS bodies failed to establish an adequate inquiry or compensation scheme despite the scale of the known harm.

The treatment of those infected and their families — in terms of financial support, medical care, and acknowledgement — was woefully inadequate.

WHY SAFECHAIN™ REFERENCES IT

The Infected Blood Inquiry is referenced in the SAFECHAIN™ programme across three specific analytical contexts.

Remedy Integrity Assessment™: AUDIT-004 was designed to assess the integrity of institutional responses to governance failures — the quality of investigation, the honesty of acknowledgement, the genuineness of remediation. The Infected Blood case is the paradigm example of remedy integrity failure: an institutional response that concealed rather than acknowledged, suppressed rather than investigated, and managed liability rather than supported those harmed. The SAFECHAIN™ AUDIT-004 framework exists because the Infected Blood pattern — of governance failure compounded by remedy failure over decades — is not unique to the NHS.

Accountability Architecture as Prevention: The SAFECHAIN™ IAR™ immutable audit architecture is designed so that governance decisions cannot be retrospectively suppressed. The Infected Blood case provides the most powerful evidence for why this design principle matters. If the governance decisions that caused and concealed the infected blood harm had been recorded in an immutable audit register attributable to the individuals who made them, the cover-up that extended the harm for decades would not have been possible.

Governance Culture Assessment: AUDIT-001 Domain 5 and the SAFECHAIN™ PC7 Governance Culture Assessment assess whether an institution's governance culture is genuinely oriented toward outcomes for the people it serves or toward institutional self-protection. The Infected Blood case documents what a governance culture of institutional self-protection produces at its worst. The SAFECHAIN™ governance culture assessment tools — and the CERT-001 certification requirement for a Strong PC7 score at Excellence level — exist because governance culture determines governance outcome, and the Infected Blood case is the proof.

RELATED SAFECHAIN™ PUBLICATIONS

AUDIT-004 — Remedy Integrity Assessment™

AUDIT-002 — Institutional Decay Audit™

AUDIT-001 — Governance Health Assessment™

GOVERN-001 — Institutional Governance Framework™

NOM-007 — Public Trust and Legitimacy Framework™

INTEL-001 — Institutional Intelligence Framework™

REPORT-001 — Annual Report Framework™ (Section 9: What We Got Wrong)

RELATED SAFECHAIN™ FRAMEWORKS

Accountability by Design™ — GLOSS-001; NOM-001

Accountability Dissolution™ — GLOSS-001

Intelligence Audit Register™ (IAR™) — GLOSS-001; NVI-003; SAT-001

Governance Culture — AUDIT-001 Domain 5; PC7 Assessment

Remedy Integrity — AUDIT-004

FURTHER READING

Full text of this source is publicly available through the official publisher. Where this source is referenced in SAFECHAIN™ publications, the specific provisions or findings cited are identified within those publications.

SAFECHAIN™ Evidence Repository articles are updated periodically as sources are revised or supplemented. To suggest a correction or an addition to this article: samantha@safe-chain.org with 'Evidence Repository' in the subject line.

© 2026 Samantha Avril-Andreassen FRSA. All rights reserved.

SAFECHAINN Ltd (Company No. 12038453).

samantha@safe-chain.org | safe-chain.org

This Evidence Repository article is the proprietary intellectual property of Samantha Avril-Andreassen. The source it describes remains the intellectual property of its original publisher. SAFECHAIN™ claims no ownership over third-party sources referenced in this article. Curation, commentary, analysis, and framework connections are proprietary to SAFECHAIN™.

No reproduction, adaptation, AI training use, or commercial use of this article without prior written permission of Samantha Avril-Andreassen and SAFECHAINN Ltd.